^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    [177Lu]FAPI-46

    i
    Associations
    News

    Trials

    Company:
    Novartis
    Drug class:
    FAP inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer (FAPI-PET) (NCT05160051)
    Phase 2
    University Hospital, Essen
    Completed
    Last update posted :
    04/12/2024
    Initiation :
    12/01/2021
    Primary completion :
    03/06/2024
    Completion :
    03/06/2024
    FAP
    |
    FAP expression
    |
    [177Lu]FAPI-46
    68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma (NCT04457258)
    Phase 1
    Jonsson Comprehensive Cancer Center
    Recruiting
    Last update posted :
    10/26/2023
    Initiation :
    09/08/2020
    Primary completion :
    07/01/2024
    Completion :
    07/21/2025
    FAP
    |
    FAP expression
    |
    [177Lu]FAPI-46
    Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation (FAPI PET Prost) (NCT04457232)
    Phase 1
    Jonsson Comprehensive Cancer Center
    Active, not recruiting
    Last update posted :
    10/13/2023
    Initiation :
    09/09/2020
    Primary completion :
    09/09/2024
    Completion :
    09/09/2025
    FAP
    |
    FAP expression
    |
    [177Lu]FAPI-46